Lucy Scientific Discovery Inc. LSDI NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score

21/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Lucy Scientific Discovery Inc. (LSDI) generated $-4.27M in operating cash flow for fiscal year 2023. After capital expenditures of $300K, free cash flow was $-4.57M.

Free cash flow margin was -64789.3% of revenue. Cash conversion ratio was 0.47x, suggesting some earnings are non-cash.

Criteria supported by this page:

HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
MOAT (32/100, Fail) — limited free cash flow weakens the competitive position
INCOME (10/100) — Cash conversion ratio was 0.47x suggests some earnings are non-cash items

Overall SharesGrow Score: 20/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

21/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

HEALTH

50/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

32/100

Proven by this page

✗

GROWTH

15/100

→ Income

✗

INCOME

10/100

→ Income

Lucy Scientific Discovery Inc. Cash Flow History

Metric	TTM	FY2023	FY2022	FY2021	FY2020
Operating Cash Flow	$-5.5M	$-4.27M	$-2.42M	$-1.48M	$-499.16K
Capital Expenditure	$-421.28K	$-300K	$-34.11K	$0.00	$0.00
Free Cash Flow	$-5.92M	$-4.57M	$-2.45M	$-1.48M	$-499.16K